Table 2.
Sex | Site | Perceived rate by participants |
Actual incidence rate (%)a) | No. (%) |
|||
---|---|---|---|---|---|---|---|
Median (IQR) | Mean±SD | Underestimation | Accurate estimation | Overestimation | |||
Men | Total | 30 (20-40) | 29.2±17.1 | 38.1 | 695 (70.1) | 123 (12.4) | 173 (17.5) |
Stomach | 20 (20-40) | 27.7±16.6 | 7.2 | 13 (1.3) | 178 (18.0) | 800 (80.7) | |
Lung | 20 (10-30) | 22.6±14.2 | 5.2 | 15 (1.5) | 276 (27.9) | 700 (70.6) | |
Liver | 20 (10-30) | 22.3±13.8 | 4.1 | 11 (1.1) | 100 (10.1) | 880 (88.8) | |
Colon, rectum | 20 (10-30) | 22.3±14.5 | 5.8 | 14 (1.4) | 311 (31.4) | 666 (67.2) | |
Prostate | 20 (10-30) | 22.2±15.4 | 3.0 | 18 (1.8) | 122 (12.3) | 851 (85.9) | |
Women | Total | 30 (20-40) | 30.0±17.7 | 33.8 | 463 (45.9) | 251 (24.9) | 295 (29.2) |
Stomach | 20 (15-35) | 27.5±17.0 | 2.9 | 9 (0.9) | 61 (6.1) | 939 (93.0) | |
Lung | 20 (10-30) | 21.5±15.2 | 1.7 | 19 (1.9) | 102 (10.1) | 888 (88.0) | |
Liver | 20 (10-30) | 21.5±14.9 | 1.1 | 20 (2.0) | 114 (11.3) | 875 (86.7) | |
Colon, rectum | 20 (10-30) | 21.4±14.4 | 2.9 | 10 (1.0) | 105 (10.4) | 894 (88.6) | |
Breast | 30 (20-35) | 27.8±15.8 | 5.3 | 2 (0.2) | 180 (17.8) | 827 (82.0) | |
Uterine cervix | 25 (15-35) | 26.7±16.6 | 1.2 | 6 (0.6) | 67 (6.6) | 936 (92.8) | |
Thyroid | 30 (15-40) | 29.4±18.2 | 12.1 | 87 (8.6) | 187 (18.5) | 735 (72.8) |
IQR, interquartile range; SD, standard deviation.
The actual lifetime cumulative incidence rates in each cancer based on cancer statistics of Korean Cancer Center Registry Data in South Korea from 2011.